Neutrophils and COVID-19: Active Participants and Rational Therapeutic Targets

Whilst the majority of individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of COVID-19, experience mild to moderate symptoms, approximately 20% develop severe respiratory complications that may progress to acute respiratory distress syndrome...

Descripción completa

Detalles Bibliográficos
Autores principales: Hazeldine, Jon, Lord, Janet M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206563/
https://www.ncbi.nlm.nih.gov/pubmed/34149717
http://dx.doi.org/10.3389/fimmu.2021.680134

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206563/
https://www.ncbi.nlm.nih.gov/pubmed/34149717
http://dx.doi.org/10.3389/fimmu.2021.680134

Ejemplares similares